|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US5998203A
(en)
|
1996-04-16 |
1999-12-07 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
|
|
DE19831710A1
(de)
|
1998-07-15 |
2000-01-20 |
Merck Patent Gmbh |
Diacylhydrazinderivate
|
|
CA2371824A1
(en)
|
1999-02-20 |
2000-08-24 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
.beta.-alanine derivatives
|
|
WO2000053722A2
(en)
|
1999-03-10 |
2000-09-14 |
Phogen Limited |
Delivery of nucleic acids and proteins to cells
|
|
DE19929410A1
(de)
|
1999-06-26 |
2000-12-28 |
Merck Patent Gmbh |
Inhibitoren des Integrins avß6
|
|
DE10028402A1
(de)
|
2000-06-13 |
2001-12-20 |
Merck Patent Gmbh |
Pyridin-2-yl-aminoalkycarbonylglycyl-beta-alanin und Derivate
|
|
US9994853B2
(en)
|
2001-05-18 |
2018-06-12 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
|
MXPA05001758A
(es)
|
2002-08-16 |
2005-08-19 |
Wyeth Corp |
Composiciones y metodos para el tratamiento de trastornos asociados a receptor para productos finales de glicatacion avanzada (rage).
|
|
EP2305813A3
(en)
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
WO2005051995A2
(en)
|
2003-11-19 |
2005-06-09 |
Curagen Corporation |
Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
|
|
EP2990410A1
(en)
|
2004-08-10 |
2016-03-02 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
|
GB0520068D0
(en)
|
2005-10-03 |
2005-11-09 |
Cancer Res Technology |
av peptide ligand
|
|
US20080213249A1
(en)
|
2006-07-07 |
2008-09-04 |
The Scripps Research Insitute |
Use of Retro-Aldol Reaction to Generate Reactive Vinyl Ketone for Attachment to Antibody Molecules by Michael Addition Reaction for Use in Immunostaining and Immunotargeting
|
|
WO2008112004A2
(en)
|
2006-08-03 |
2008-09-18 |
Astrazeneca Ab |
ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF
|
|
CN101500548A
(zh)
|
2006-08-18 |
2009-08-05 |
弗·哈夫曼-拉罗切有限公司 |
用于体内递送多核苷酸的多缀合物
|
|
US20110003858A1
(en)
|
2006-09-04 |
2011-01-06 |
Bergstroem Lena |
Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
|
|
AR066984A1
(es)
|
2007-06-15 |
2009-09-23 |
Novartis Ag |
Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia)
|
|
WO2009069727A1
(ja)
|
2007-11-28 |
2009-06-04 |
Fujifilm Corporation |
生体高分子およびポリペプチドの化学修飾方法
|
|
CN102596922A
(zh)
|
2009-10-06 |
2012-07-18 |
免疫基因公司 |
有效的缀合物和亲水性连接体
|
|
GB0922014D0
(en)
|
2009-12-17 |
2010-02-03 |
Ge Healthcare Ltd |
Novel integrin binders
|
|
PH12012501596A1
(en)
|
2010-02-24 |
2017-02-03 |
Arrowhead Res Corporation |
Compositions for targeted delivery of sirna
|
|
US9920317B2
(en)
*
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
CA2842039A1
(en)
|
2011-08-26 |
2013-03-07 |
Arrowhead Research Corporation |
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
|
|
CN105017420B
(zh)
|
2012-02-17 |
2019-05-28 |
西雅图基因公司 |
针对整联蛋白αvβ6的抗体和使用该抗体治疗癌症
|
|
EP2650013A1
(en)
|
2012-04-10 |
2013-10-16 |
Deutsches Krebsforschungszentrum |
Inhibitors of Receptor for Advanced Glycation-End products (RAGE) for use in treating and/or preventing inflammation- and/or damage-induced cancer
|
|
MX2014001965A
(es)
|
2012-04-18 |
2014-03-31 |
Arrowhead Res Corp |
Polimeros de poli(acrilato) para suministro de acido nucleico in vivo.
|
|
JP2014029990A
(ja)
|
2012-06-29 |
2014-02-13 |
Sharp Corp |
窒化物半導体装置の電極構造およびその製造方法並びに窒化物半導体電界効果トランジスタ
|
|
PT2978840T
(pt)
|
2013-03-26 |
2021-01-06 |
Univ Of Artois |
Um modelo de barreira hematoencefálica humana derivado de células estaminais
|
|
JP2015040181A
(ja)
|
2013-08-20 |
2015-03-02 |
学校法人立命館 |
カロテノイドの新規用途、並びにバリア機能改善薬のスクリーニング方法
|
|
BR112016004153A2
(pt)
|
2013-08-28 |
2019-09-17 |
Caris Life Sciences Switzerland Holdings Gmbh |
"método para caracterizar uma doença ou distúrbio, kit, composição, método para gerar uma biblioteca de entrada, oligonucleotídeo, pluralidade de oligonucleotídeos e método para identificar um aptâmero
|
|
EP2913064A1
(en)
|
2014-02-26 |
2015-09-02 |
celares GmbH |
Branched drug-linker conjugates for the coupling to biological targeting molecules
|
|
KR101602261B1
(ko)
*
|
2014-04-01 |
2016-03-10 |
연세대학교 산학협력단 |
폴리플렉스 전달 시스템을 포함하는 부정맥 치료 또는 예방용 조성물
|
|
WO2015160770A1
(en)
|
2014-04-15 |
2015-10-22 |
The Regents Of The University Of California |
Bi-terminal pegylated integrin-binding peptides and methods of use thereof
|
|
WO2015179823A2
(en)
|
2014-05-23 |
2015-11-26 |
The California Institute For Biomedical Research |
Lung localized inhibitors of alpha(v)beta 6
|
|
US9803201B2
(en)
|
2015-03-17 |
2017-10-31 |
Arrowhead Pharmaceuticals, Inc. |
Disulfide-containing alkyne linking agents
|
|
TWI761305B
(zh)
|
2015-05-29 |
2022-04-21 |
美商愛羅海德製藥公司 |
抑制Hif2α基因表現之組合物及方法
|
|
TWI912633B
(zh)
|
2016-06-06 |
2026-01-21 |
美商愛羅海德製藥公司 |
5'-環-磷酸修飾之核苷酸
|
|
JOP20190015A1
(ar)
|
2016-08-04 |
2019-02-04 |
Arrowhead Pharmaceuticals Inc |
عوامل (ار ان ايه آي) لعدوى فيروس الالتهاب الكبدي الوبائي ب
|
|
AU2017354041B2
(en)
|
2016-11-01 |
2024-02-01 |
Arrowhead Pharmaceuticals, Inc. |
Alpha-V beta-6 integrin ligands and uses thereof
|
|
SG11202002967SA
(en)
|
2017-11-01 |
2020-05-28 |
Arrowhead Pharmaceuticals Inc |
Integrin ligands and uses thereof
|
|
CN120247964A
(zh)
|
2018-02-17 |
2025-07-04 |
箭头药业股份有限公司 |
三炔连接剂和使用方法
|
|
WO2021029896A1
(en)
|
2019-08-15 |
2021-02-18 |
Lifesplice Pharma Llc |
Splice modulating oligonucleotides targeting receptor for advanced glycation end products and methods of use
|
|
EP4496579A2
(en)
*
|
2022-03-22 |
2025-01-29 |
Arrowhead Pharmaceuticals, Inc. |
Subcutaneous delivery of rnai agents for inhibiting expression of receptor for advanced glycation end-products (rage)
|